Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051402 · ClinicalTrials.gov registry record · Phase 2
Phytoestrogens and Memory Decline in Menopause
A Phase 2 study of Memory Loss and Postmenopause, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT00051402 is a Phase 2 study of Memory Loss and Postmenopause that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 96 participants, below the 403-participant average among 12 other Memory Loss trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00051402, a Phase 2 study of Memory Loss and Postmenopause, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether soy-derived phytoestrogens taken as dietary supplements improve memory function in postmenopausal women who have experienced early memory decline.
Conditions Studied
Interventions
- DRUG Isoflavones
Study Locations (1)
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00051402
The ClinicalTrials.gov registry entry for NCT00051402 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 403-participant average among 12 other Memory Loss trials with a reported enrollment target (76% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Memory Loss appearing as the primary indexed condition, and to 1 intervention - of which Isoflavones is the first listed.
NCT00051402 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00051402 about?
NCT00051402 is a clinical study titled "Phytoestrogens and Memory Decline in Menopause". The purpose of this study is to investigate whether soy-derived phytoestrogens taken as dietary supplements improve memory function in postmenopausal women who have experienced early memory decline.
What is the current status of trial NCT00051402?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2002-12. Estimated completion is 2007-08.
What conditions does trial NCT00051402 study?
This clinical trial studies the following conditions: Memory Loss, Postmenopause.
What interventions are being tested in trial NCT00051402?
The interventions under investigation include: Isoflavones (DRUG).
Who is sponsoring clinical trial NCT00051402?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00051402 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Memory Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
RECRUITING
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Brain Health Virtual Reality Study
RECRUITING · NA
-
Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities
RECRUITING · NA
-
Pharmacological Modulation of Brain Oscillations in Memory Processing
RECRUITING · Early Phase 1
-
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.